Condition: Tricuspid Regurgitation · Pacemaker Complication · Sponsor: LMU Klinikum
This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years.
This description comes directly from the study's public registry record.
Daniel Braun, MD · +4989440072371 · daniel.braun@med.uni-muenchen.de
Jonas Gmeiner, MD · +4989440072371 · jonas.gmeiner@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| LMU Klinikum | Munich, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05667519